Jeffrey Eisenberg
No más puestos en curso
Fortuna: 1 626 $ al 31/05/2024
Perfil
Jeffrey F.
Eisenberg served as President, Chief Executive Officer & Director at Noven Pharmaceuticals, Inc. from 2009 to 2016.
He then became Chief Executive Officer & Director at Xenetic Biosciences, Inc. from 2017 to 2024.
Additionally, he was an Independent Director at MabVax Therapeutics Holdings, Inc. from 2016 to 2018.
Prior to these roles, he worked as Associate General Counsel at IVAX LLC from 1995 to 1998.
He also served as President at Novogyne Pharmaceuticals from 2007 to 2014.
Mr. Eisenberg holds a graduate degree from Columbia Law School and an undergraduate degree from The Wharton School of the University of Pennsylvania.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/03/2024 | 417 ( 0.03% ) | 1 626 $ | 31/05/2024 |
Antiguos cargos conocidos de Jeffrey Eisenberg.
| Empresas | Cargo | Fin |
|---|---|---|
| XENETIC BIOSCIENCES, INC. | Director Ejecutivo | 16/05/2024 |
| MABVAX THERAPEUTICS HOLDINGS, INC. | Director/Miembro de la Junta | 31/07/2018 |
Noven Pharmaceuticals, Inc.
 Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Director Ejecutivo | 01/01/2016 |
Novogyne Pharmaceuticals
 Novogyne Pharmaceuticals Pharmaceuticals: MajorHealth Technology Novogyne Pharmaceuticals manufactures pharmaceutical products. | Presidente | 01/08/2014 |
IVAX LLC
 IVAX LLC Pharmaceuticals: MajorHealth Technology IVAX LLC discovers, develops, manufactures, and markets generic pharmaceuticals, respiratory drugs, and cancer treatments. It offers drugs for the treatment of multiple sclerosis, brain cancer, asthma, and epilepsy. The company was founded by Phillip Frost and Jane H. Hsiao in 1987 and is headquartered in Weston, FL. | Consejero General | - |
Formación de Jeffrey Eisenberg.
| Columbia Law School | Graduate Degree |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| XENETIC BIOSCIENCES, INC. | Health Technology |
| Empresas privadas | 6 |
|---|---|
IVAX LLC
IVAX LLC Pharmaceuticals: MajorHealth Technology IVAX LLC discovers, develops, manufactures, and markets generic pharmaceuticals, respiratory drugs, and cancer treatments. It offers drugs for the treatment of multiple sclerosis, brain cancer, asthma, and epilepsy. The company was founded by Phillip Frost and Jane H. Hsiao in 1987 and is headquartered in Weston, FL. | Health Technology |
Noven Pharmaceuticals, Inc.
Noven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Noven Pharmaceuticals, Inc. operates as a pharmaceutical company with transdermal expertise. It specializes in the research and development, manufacture, marketing, and sale of prescription pharmaceutical products. The company was founded in 1987 and is headquartered in Miami, FL. | Health Technology |
MabVax Therapeutics, Inc.
 MabVax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology MabVax Therapeutics, Inc. developed and commercialized immunotherapeutics for the treatment of cancer. The company was founded in 2006 and is headquartered in San Diego, CA. | Health Technology |
Steel Hector & Davis LLP
 Steel Hector & Davis LLP Miscellaneous Commercial ServicesCommercial Services Part of Squire Patton Boggs (US) LLP, Steel Hector & Davis LLP provides legal services. The company is based in Miami, FL. Steel Hector & Davis was acquired by Squire Sanders (US) LLP on September 06, 2005. | Commercial Services |
MabVax Therapeutics Holdings, Inc.
 MabVax Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology MabVax Therapeutics Holdings, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA. | Health Technology |
Novogyne Pharmaceuticals
Novogyne Pharmaceuticals Pharmaceuticals: MajorHealth Technology Novogyne Pharmaceuticals manufactures pharmaceutical products. | Health Technology |
- Bolsa de valores
- Insiders
- Jeffrey Eisenberg
